Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients (>= 6 to < 12 year of age): results from CADMUS Jr
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY（2019）
关键词
Psoriasis,Pediatric,Ustekinumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要